Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical organizations, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably safe for use – and failure to perform so may possibly be grounds for compensation. Our lawyers are working difficult to have those hurt by the drug the compensation they are entitled to.
While bleeding can be a widespread complication linked with anticoagulants, it has been alleged that Xarelto is a lot more unsafe than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This indicates that, within the event of an emergency, patients may possibly be look at these guys risk for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.
Should you or a loved one particular suffered a critical bleeding event soon after taking Xarelto, you might have legal recourse. For much more information, speak to us right now to possess your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral expenditures. Moreover, they’re searching for punitive damages, that are typically awarded to punish the defendant and deter other companies from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs inside the lawsuits allege severe and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for a lot more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.